Genetic sharing among evolutionary neighbors all happens through hybrids: the offspring produced when individuals from two ...
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. ("LIR" or the "Company") announces that it has filed a provisional patent application intended to cover a needle-free ...
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who are ...
The CALM-CAH Phase 3 study is a randomized, placebo-controlled trial evaluating atumelnant in adults with classic CAH, designed to assess reductions in excess androgens, improvements in glucocorticoid ...